The compound Z-N-methyl-L-aspartic acid b-tert-butyl ester dicyclohexylammonium salt is a versatile chemical with significant applications in the fields of pharmaceuticals and biochemistry. This compound is recognized for its role as a potent NMDA receptor agonist, making it valuable in neuropharmacological research. Its unique structure allows for enhanced solubility and stability, which are critical for various experimental setups. Researchers utilize this compound to study synaptic transmission and neurodegenerative diseases, providing insights that could lead to novel therapeutic approaches.

Moreover, the dicyclohexylammonium salt form of this compound enhances its bioavailability, making it suitable for in vivo studies. Its applications extend to the development of new drugs targeting neurological disorders, as well as in the synthesis of other complex organic molecules. The compound's favorable properties, such as its ability to cross the blood-brain barrier, position it as a promising candidate for further exploration in drug development and neurobiology.